Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
NF-κB signaling, liver disease and hepatoprotective agents — Beicheng Sun (2008) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
NF-κB signaling, liver disease and hepatoprotective agents
Shared by
Michael Karin
University of California, San Diego
NF-κB signaling, liver disease and hepatoprotective agents
Article
2008
en
Related publications
Book
2011
NF-κB in health and disease
Michael Karin
Article
2007
Signaling to NF-κB by Toll-like receptors
Taro Kawai
,
Akira Shizuo
Trends in Molecular Medicine
Article
2005
The Anti-Death Machinery in IKK/NF-κB Signaling
Authors
BS
Beicheng Sun
Michael Karin
University of California, San Diego
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Jun‐Li Luo
,
Hideaki Kamata
,
Michael Karin
Article
2010
NF-κB and STAT3 – key players in liver inflammation and cancer
Guobin He
,
Michael Karin
Article
2019
Targeting NF-κB signaling pathway in cancer by dietary polyphenols
Haroon Khan
,
Hammad Ullah
,
Paula C. Castilho
,
Antonio García‐Ríos
,
Grazia D’Onofrio
,
Rosanna Filosa
,
Fang Wang
,
Seyed Mohammad Nabavi
,
Maria Daglia
,
A. Sanches‐Silva
,
Kannan R. R. Rengasamy
,
Juanying Ou
,
Xiaobo Zou
,
Jianbo Xiao
,
Hui Cao
Discussion(0)
No comments yet. Be the first to comment.